Drug
BI 113823 Ketokonazole
BI 113823 Ketokonazole: highest development phase Phase 1, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| BI 113823 + Ketokonazole NCT01189175 | Phase 1 | Healthy |
Latest
No recent events.
Follow BI 113823 Ketokonazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.